局部晚期恶性实体瘤的临床试验
总计11641个结果
-
Turning Point Therapeutics, Inc.撤销
-
Hanmi Pharmaceutical Company Limited主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人
-
Jiangsu vcare pharmaceutical technology co., LTD招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Advanced Integrative Medical Science Institute招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Avistone Biotechnology Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; Peking University Cancer... 和其他合作者招聘中
-
Pierre Fabre Medicament终止
-
OncoMed Pharmaceuticals, Inc.Celgene Corporation完全的
-
Sameek Roychowdhury主动,不招人
-
National Cancer Institute (NCI)尚未招聘局部晚期恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤 | 临床 III 期胃癌 AJCC v8 | 临床 III 期胃食管结合部腺癌 AJCC v8 | 临床 IV 期胃癌 AJCC v8 | 临床 IV 期胃食管结合部腺癌 AJCC v8 | 转移性胃食管结合部腺癌 | 不可切除的胃食管结合部腺癌 | 局部晚期胃食管结合部腺癌 | 转移性胃癌 | 局部晚期胃癌 | 不可切除的胃癌
-
Merck Sharp & Dohme LLCAstraZeneca完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Tianhong LiNational Cancer Institute (NCI); OncoImmune, Inc.终止
-
Dong-A ST Co., Ltd.尚未招聘
-
Chinese PLA General HospitalWuxi Sinotide New Drug Discovery Institutes招聘中
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中
-
Shanghai East HospitalImbioray (Hangzhou) Biomedicine Co., Ltd.招聘中
-
National Cancer Institute (NCI)主动,不招人